Northern Capital Management LLC trimmed its position in shares of CVS Health Corp (NYSE:CVS) by 2.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,884 shares of the pharmacy operator’s stock after selling 1,546 shares during the period. Northern Capital Management LLC’s holdings in CVS Health were worth $3,725,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Camarda Financial Advisors LLC acquired a new stake in CVS Health during the 2nd quarter valued at $102,000. Quantbot Technologies LP acquired a new position in CVS Health during the 1st quarter worth $103,000. Kiley Juergens Wealth Management LLC acquired a new position in CVS Health during the 2nd quarter worth $103,000. Wagner Wealth Management LLC acquired a new position in CVS Health during the 4th quarter worth $114,000. Finally, Legacy Advisors LLC grew its holdings in CVS Health by 7,100.0% during the 2nd quarter. Legacy Advisors LLC now owns 1,800 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,775 shares in the last quarter. 82.80% of the stock is owned by institutional investors and hedge funds.
CVS Health stock opened at $69.05 on Friday. The company has a debt-to-equity ratio of 1.73, a quick ratio of 1.88 and a current ratio of 2.34. CVS Health Corp has a 1 year low of $60.14 and a 1 year high of $84.00. The stock has a market capitalization of $69.81 billion, a PE ratio of 11.70, a price-to-earnings-growth ratio of 0.92 and a beta of 0.96.
CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.61 by $0.08. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. During the same period last year, the firm posted $1.33 EPS. The company’s revenue for the quarter was up 2.2% on a year-over-year basis. research analysts expect that CVS Health Corp will post 7.04 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th were given a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, July 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.90%. CVS Health’s payout ratio is currently 33.90%.
Several research analysts have weighed in on the stock. Loop Capital set a $68.00 price objective on shares of CVS Health and gave the stock a “hold” rating in a report on Monday, May 7th. Leerink Swann set a $80.00 price objective on shares of CVS Health and gave the stock an “outperform” rating in a report on Thursday. Citigroup reissued a “buy” rating and set a $81.00 price objective on shares of CVS Health in a report on Monday, July 9th. ValuEngine lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Finally, Morgan Stanley decreased their price objective on shares of CVS Health from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Tuesday, July 3rd. Three investment analysts have rated the stock with a sell rating, five have given a hold rating, eleven have given a buy rating and two have given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $85.80.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Further Reading: Growth Stocks
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.